Sonia M. Brodie

Sonia M. Brodie

Auto-generated profile, based on publicly available information

Sonia M. Brodie

Centre for Neurology Studies, HealthTech Connex, Metro Vancouver, BC, Canada

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2015 in Neuropsychologia
Verified
Journal Article
Open access
MBMichael Borich
Michael Borich
SBS.M. Brodie
S.M. Brodie
WGW.A. Gray
W.A. Gray
Silvio IontaSilvio Ionta
Silvio Ionta
LBL.A. Boyd
L.A. Boyd
Emerging evidence indicates impairments in somatosensory function may be a major contributor to motor dysfunction associated with neurologic injury or disorders. However, the neuroanatomical substrates underlying the connection between aberrant sensory input and ineffective motor output are still under investigation. The primary somatosensory cortex (S1) plays a critical role in processing afferent somatosensory input and contributes to the integration of sensory and motor signals necessary for skilled movement. Neuroimaging and neurostimulation approaches provide unique opportunities to non-invasively study S1 structure and function including connectivity with other cortical regions. These research techniques have begun to illuminate casual contributions of abnormal S1 activity and connectivity to motor dysfunction and poorer recovery of motor function in neurologic patient populations. This review synthesizes recent evidence illustrating the role of S1 in motor control, motor learning and functional recovery with an emphasis on how information from these investigations may be exploited to inform stroke rehabilitation to reduce motor dysfunction and improve therapeutic outcomes.

1 October 2018 in Anesthesia & Analgesia
Verified
Journal Article
Closed access
NWNicholas West
Nicholas West
KHKlaske van Heusden
Klaske van Heusden
Matthias GörgesMatthias Görges
Matthias Görges
SBSonia Brodie
Sonia Brodie
ARAryannah Rollinson
Aryannah Rollinson
RMRichard N. Merchant
Richard N. Merchant
BACKGROUND: Closed-loop control of anesthesia involves continual adjustment of drug infusion rates according to measured clinical effect. The NeuroSENSE monitor provides an electroencephalographic measure of depth of hypnosis (wavelet-based anesthetic value for central nervous system monitoring [WAVCNS]). It has previously been used as feedback for closed-loop control of propofol, in a system designed using robust control engineering principles, which implements features specifically designed to ensure patient safety. Closed-loop control of a second drug, remifentanil, may be added to improve WAVCNSstability in the presence of variable surgical stimulation. The objective of this study was to design and evaluate the feasibility of a closed-loop system for robust control of propofol and remifentanil infusions using WAVCNSfeedback, with an infusion safety system based on the known pharmacological characteristics of these 2 drugs.METHODS: With Health Canada authorization, research ethics board approval, and informed consent, American Society of Anesthesiologists I–III adults, requiring general anesthesia for elective surgery, were enrolled in a 2-phase study. In both phases, infusion of propofol was controlled in closed loop during induction and maintenance of anesthesia, using WAVCNSfeedback, but bounded by upper- and lower-estimated effect-site concentration limits. In phase I, remifentanil was administered using an adjustable target-controlled infusion and a controller was designed based on the collected data. In phase II, remifentanil was automatically titrated to counteract rapid increases in WAVCNS.RESULTS: Data were analyzed for 127 patients, of median (range) age 64 (22–86) years, undergoing surgical procedures lasting 105 (9–348) minutes, with 52 participating in phase I and 75 in phase II. The overall control performance indicator, global score, was a median (interquartile range) 18.3 (14.2–27.7) in phase I and 14.6 (11.6–20.7) in phase II (median difference, −3.25; 95% confidence interval, −6.35 to −0.52). The WAVCNSwas within ±10 of the setpoint for 84.3% (76.6–90.6) of the maintenance of anesthesia in phase I and 88.2% (83.1–93.4) in phase II (median difference, 3.7; 95% confidence interval, 0.1–6.9). The lower propofol safety bound was activated during 30 of 52 (58%) cases in phase I and 51 of 75 (68%) cases in phase II.CONCLUSIONS: Adding closed-loop control of remifentanil improved overall controller performance. This controller design offers a robust method to optimize the control of 2 drugs using a single sensor. The infusion safety system is an important component of a robust automated anesthesia system, but further research is required to determine the optimal constraints for these safe conditions.

21 March 2014 in Frontiers in Human Neuroscience
Verified
Journal Article
Open access
PDF file
SBSonia M. Brodie
Sonia M. Brodie
Sean K MeehanSean K Meehan
Sean K Meehan
MBMichael R. Borich
Michael R. Borich
LBLara A. Boyd
Lara A. Boyd
Sensory feedback is critical for motor learning, and thus to neurorehabilitation after stroke. Whether enhancing sensory feedback by applying excitatory repetitive transcranial magnetic stimulation (rTMS) over the ipsilesional primary sensory cortex (IL-S1) might enhance motor learning in chronic stroke has yet to be investigated. The present study investigated the effects of 5 Hz rTMS over IL-S1 paired with skilled motor practice on motor learning, hemiparetic cutaneous somatosensation, and motor function. Individuals with unilateral chronic stroke were pseudo-randomly divided into either Active or Sham 5 Hz rTMS groups (n=11/group). Following stimulation, both groups practiced a Serial Tracking Task (STT) with the hemiparetic arm; this was repeated for 5 days. Performance on the STT was quantified by response time, peak velocity, and cumulative distance tracked at baseline, during the 5 days of practice, and at a no-rTMS retention test. Cutaneous somatosensation was measured using two-point discrimination. Standardized sensorimotor tests were performed to assess whether the effects might generalize to impact hemiparetic arm function. The active 5Hz rTMS + training group demonstrated significantly greater improvements in STT performance [response time (F1,286.04=13.016, p< 0.0005), peak velocity (F1,285.95=4.111, p=0.044), and cumulative distance (F1,285.92=4.076, p=0.044)] and cutaneous somatosensation (F1,21.15=8.793, p=0.007) across all sessions compared to the sham rTMS + training group. Measures of upper extremity motor function were not significantly different for either group. Our preliminary results suggest that, when paired with motor practice, 5Hz rTMS over IL-S1 enhances motor learning related change in individuals with chronic stroke, potentially as a consequence of improved cutaneous somatosensation, however no improvement in general upper extremity function was observed.

1 October 2015 in Clinical Neurophysiology
Verified
Journal Article
Closed access
Cameron S MangCameron S Mang
Cameron S Mang
MBMichael R. Borich
Michael R. Borich
SBSonia M. Brodie
Sonia M. Brodie
KBKatlyn E. Brown
Katlyn E. Brown
NSNicholas Snow
Nicholas Snow
LBLara A. Boyd
Lara A. Boyd

1 April 2016 in Neuroscience Letters
Verified
Journal Article
Closed access
MBMichael Borich
Michael Borich
LWLewis A. Wheaton
Lewis A. Wheaton
SBSonia M. Brodie
Sonia M. Brodie
BLBimal Lakhani
Bimal Lakhani
LBLara A. Boyd
Lara A. Boyd

16 September 2014 in European Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
SBSonia M. Brodie
Sonia M. Brodie
MBMichael R. Borich
Michael R. Borich
LBLara A. Boyd
Lara A. Boyd